Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Event Logistics

- PMLiVE

Rebuffed Horizon tries to replace Depomed board members

But firm says latest deal 'significantly undervalues' Depomed

- PMLiVE

EU green light for Novartis’ skin cancer therapy

Swiss firm’s basal cell carcinoma treatment can now be launched across Europe

- PMLiVE

FDA slams Kardashian West’s Instagram drug promotion

Morning-sickness drug firm Duchesnay criticised over social media marketing

Roche Basel Switzerland

Roche buys gene sequencing firm

Swiss firm has been working with Kapa for two years but is now acquiring the company

- PMLiVE

Drivers for change – payer value perceptions

In an ever-changing healthcare environment, the need to prove value for money remains a key focus for payers and reimbursement decision makers.

- PMLiVE

FDA approves first female sexual disorder drug

The ‘little pink pill’ has had a difficult path to market and comes with safety warnings

- PMLiVE

FDA grants priority review for new Keytruda licence

Merck’s PD-1 drug being assessed for first-line melanoma patients

Can Cinderella save us?

NICE gets tough on antibiotic prescribers

Watchdog says the threat of antimicrobial resistance must be tackled now

- PMLiVE

Novartis licenses cancer support drug from Aveo Oncology

Swiss firm buys into drug to alleviate a wasting syndrome that is seen in chronic patients

- PMLiVE

Mylan joins forces with Disney on allergy treatment

Builds on its 2014 deal with the firm for its EpiPen treatment

How to use animations in e-detailing

Do you feel that you have to compete to have the most advanced 3-D model? A gorgeous animation? Relax. E-detailing content doesn’t have to be flashy & fancy – relevant...

Anthill Agency

Roche Basel Switzerland

Roche’s PD-L1 drug shrinks lung tumours

Drug has already showed success in treating certain bladder cancer patients

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links